Life Science Leader Blogs

  1. Gender Diversity In Leadership - How Does Biopharma Compare? 2/12/2018

    How the 10 largest publicly traded biopharmaceutical companies compare to 10 of the largest publicly traded nonbiopharmaceutical companies in the area of gender diversity among executive leadership.

  2. Is It Time For Branded Biopharmaceuticals To Get Into The Business Of Generics? 2/5/2018

    With President Trump’s recently announced focus on reducing the price of prescription drugs, perhaps it is time branded biopharmaceutical companies consider competing in other areas beyond just biosimilars (i.e., generic biologics).

  3. Does Drug Development Require A Passionate Commitment? 1/26/2018

    Successful drug discovery and development requires a passionate commitment, something that can only be displayed during the breakout sessions at the J.P. Morgan annual healthcare conference.

  4. JPM — More Than A Gap In Gender 1/24/2018

    While some continue to focus on the lack of gender diversity at the annual J.P. Morgan healthcare conference, GSK’s CEO, Emma Walmsley, notes that supporting diversity means doing more than just focusing on the “gender agenda.”

  5. Connectivity — The Beauty Of JPM And BTS 1/22/2018

    The annual J.P. Morgan and Biotech Showcase conferences not only provide great networking opportunities, they expose you to interesting and cutting-edge companies to keep on your radar.

  6. Industry's Reflected Gold 1/18/2018

    In my travels, I’ve especially noted three areas of unavoidable transformation due to forces quite beyond the industry’s control: women’s advocacy, the drug-pricing stalemate, and the new politics.

  7. Can JPM And BTS Make A Bigger Difference? 1/18/2018

    An idea for how the biopharmaceutical and life science industries could make a bigger difference during the annual January JPM invasion of San Francisco.

  8. How Will You Respond When Social Media Targets Your Company — Or You? 1/3/2018

    Important lessons learned from the 2014 #SaveJosh social media firestorm that engulfed Chimerix, as well as the company’s former CEO, Ken Moch.

  9. A Behind The Scenes Look Into Planning For BIO 2018 — Thus Far 12/13/2017

    A behind the scenes look into the educational planning for the 2018 BIO International Convention in Boston.

  10. More from the Women of Biopharma — Full Measures of Progress 12/8/2017

    In the December 2017 issue’s article, “The Women of Biopharma — Will They Gain or Lose Ground in 2018?” we summarize the responses of those who chose to contribute as panelists in a “virtual roundtable” discussion. Here, as promised, we are posting their written responses in full.